Press releases
-
05/23/2023 - 22:53
Availability of the Exemption document
-
04/17/2023 - 07:00
Pherecydes Pharma presented its Phagogram 1.5 at the ECCMID Congress
-
03/27/2023 - 07:00
Pherecydes Pharma selected for the French Tech Health20 program’s 2023 class
-
01/03/2023 - 17:45
Pherecydes Pharma Announces its Financial Agenda for 2023
-
10/27/2022 - 17:45
Half-year 2022 financial results and update on the development plan
-
09/22/2022 - 08:30
Pherecydes Pharma successfully completes €3.1 million capital increase
-
03/11/2022 - 07:00
Pherecydes Pharma and BIOASTER join forces in the treatment of bacteremia
-
01/10/2022 - 17:45
Pherecydes Pharma Announces its Financial Agenda for 2022
-
04/28/2021 - 07:00
Portzamparc initiates the coverage of Pherecydes Pharma
-
03/22/2021 - 18:00
Pherecydes Pharma Announces its Financial Agenda for 2021